- Main
Investigating the immune response to Mycobacterium tuberculosis complex (MTBC) variable antigens
- Howard, Zach Patrick
- Advisor(s): Ernst, Joel D;
- Javid, Babak
Abstract
Mycobacterium tuberculosis is the leading cause of death globally due to a single infectious agent. Currently, no effective vaccine against pulmonary tuberculosis, the primary adult disease caused by Mtb infection, exists. A large body of evidence suggests that CD4 T cell responses to Mtb infection are required to prevent disease, and thus most current vaccine studies aim to induce protective CD4 T cell responses. Unlike viral pathogens or bacteria that produce a toxin, Mtb has an exceptionally large number of suitable CD4 T cell antigens and ideal targets for inclusion in a vaccine have not been exhaustively identified. Intriguingly, efforts to identify signs of antigenic variation within the Mycobacterium tuberculosis complex, revealed that T cell antigens are hyperconserved. This suggests that most dominant T cell epitopes are not inducing immune responses that exert a selective pressure on Mtb during infection and may not be suitable for a vaccine. Additional studies identified a rare subset of antigens that did exhibit sequence variation within predicted T cell epitopes. I hypothesized that T cell responses to these antigens may be more protective. Utilizing a DNA vaccine platform and aerosol infection of multiple strains of mice, I was able to demonstrate that a vaccination with these antigens induced a CD4 T cell response and altered pathology in two strains of mice, independent of bacterial burden. I further demonstrated significant changes to the immune cell subsets responding to infection and to the characteristic granulomatous lesion mediated by variable antigen vaccination. Additionally, I showed that vaccination with these antigens significantly changed the immune cell composition in the lungs during infection. Lastly, I established novel experimental methods that will aid in investigating the mechanisms underlying these unique impacts of CD4 T cell responses to variable Mtb antigens.